This information is intended for US healthcare professionals.
A diabetes mellitus antibody panel examines blood for the presence of islet autoantibody proteins. These proteins indicate the autoimmune process in the pancreas has begun. This test is available through most diagnostic labs in the US.1,2
Support systems are available for families and patients with T1D. There is a network of advocates, healthcare providers, and educational groups ready to get involved today.
JDRF, the leading global funder of T1D research, has launched a groundbreaking screening initiative for T1D: T1Detect.VISIT NOW
TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams at the forefront of T1D research.VISIT NOW
Taking Control of Your Diabetes (TCOYD) is an educational advocacy group for patients and the larger T1D community.VISIT NOW
Beyond Type 1 is a nonprofit focusing on advocacy, education, and the path to a cure for T1D.VISIT NOW
Access more information about diabetes and which laboratory testing services are available through Quest Diagnostics™.VISIT NOW
Access the Diabetes Autoimmune Profile page for testing information and ordering instructions.VISIT NOW
1. Ziegler A-G, Kick K, Bonifacio E, et al; for Fr1da Study Group. Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. JAMA. 2020;323(4):339-351.
2. Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964-1974.